ICD-10-CM Billable Code

M61.177

Myositis ossificans progressiva, right toe(s)

Clinical Classification Guidelines

Medical Intelligence & Overview

Myositis ossificans progressiva (MOP) in the right toe is a rare, progressive condition characterized by abnormal bone formation within soft tissues, specifically affecting the toes. This condition leads to unusual bone growth that can impair mobility and cause discomfort. Although closely related to more common forms of heterotopic ossification, MOP is distinguished by its degenerative and progressive nature, often requiring specialized attention from healthcare professionals.

Causes & Symptoms

Clinical Causes: Genetic mutations: Myositis ossificans progressiva is typically caused by mutations in the ACVR1 gene, which play a vital role in bone development and repair. Inherited condition: It is an autosomal dominant disorder, meaning only one copy of the mutated gene can cause the disease. Trauma or injury: Though less commonly, trauma or injury may exacerbate the condition or trigger its progression.

Key Symptoms: Gradual swelling and hardening of soft tissues in the affected toe. Progressive loss of toe mobility, leading to stiffness and deformity. Formation of bony bumps or nodules around the toe joint. Pain and tenderness during movement or touch. Potential restriction of normal toe function, affecting walking or balance.

Diagnostic & Treatment

Diagnosis Path: Diagnosis is primarily based on clinical evaluation and imaging studies. Healthcare providers may use X-rays to identify abnormal bone formation and MRI scans to differentiate MOP from other soft tissue conditions. Genetic testing can confirm mutations in the ACVR1 gene, supporting a definitive diagnosis. A detailed medical history including family history is also essential due to the inherited nature of the disorder.

Treatment Protocols: Currently, there is no cure for myositis ossificans progressiva. Management focuses on alleviating symptoms and improving quality of life. Treatment options may include:

Reimbursement claims with a date of service on or after October 1, 2015 require the use of ICD-10-CM codes.

Clinical Advice & FAQs

Billing Guidance

Is M61.177 a billable ICD-10 code?
Yes, M61.177 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.

Documentation

How do I report M61.177?
Clinical documentation must specify the nature of Myositis ossificans progressiva, right toe(s) and any associated comorbidities for accurate reporting.

Cite this Clinical Reference